Madrid, Spain - Thrombotargets Corporation announced today that it is relocating its headquarters in United States to the Research Triangle Park in North Carolina. The effective date for the relocation is March 1st, 2007.
The new address of Thrombotargets Corporation since that date will be: 2530 Meridian Parkway, Suite 3023 Durham, NC 27713
“The relocation to RTP is an important and necessary step in the growing process of Thrombotargets” said Dr Pedreño, President/CEO, Thrombotargets Corp.
The decision was taken after analyzing different relocation options and taking in account that RTP serves as headquarter for more that 145 organizations and more than 120 research and development-related organizations.
Thrombotargets is willing to start a fruitful collaboration with North Carolina State Institutions as well as with North Carolina Biotechnology Center and the three significant Universities located in the vicinity of RTP.
